Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.

Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.

Previous studies suggest that protective immunity against Schistosoma haematobium is primarily stimulated by antigens from dying worms. Praziquantel treatment kills adult worms, boosting antigen exposure and protective antibody levels. Current schistosomiasis control efforts use repeated mass drug a...

Full description

Bibliographic Details
Main Authors:	Kate M Mitchell, Francisca Mutapi, Takafira Mduluza, Nicholas Midzi, Nicholas J Savill, Mark E J Woolhouse
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC4117464?pdf=render

Similar Items

Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
by: Francisca Mutapi, et al.
Published: (2011-05-01)

The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium
by: Mutapi Francisca, et al.
Published: (2002-01-01)

Cytokine responses to <it>Schistosoma haematobium </it>in a Zimbabwean population: contrasting profiles for IFN-γ, IL-4, IL-5 and IL-10 with age
by: Mduluza Takafira, et al.
Published: (2007-11-01)

Chitinase 3-like 1 protein levels are elevated in Schistosoma haematobium infected children.
by: Laura J Appleby, et al.
Published: (2012-01-01)

Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children.
by: Gemma Louise Kay, et al.
Published: (2015-01-01)

Immuno-epidemiology of human <it>Schistosoma haematobium </it>infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden
by: Fernandez Cecilia, et al.
Published: (2006-06-01)

Effect of Schistosoma haematobium infection on the cognitive functions of preschool age children and benefits of treatment from an endemic area in Zimbabwe
by: Maritha Kasambala, et al.
Published: (2022-10-01)

The association of systemic inflammation and cognitive functions of pre-school aged children residing in a Schistosoma haematobium endemic area in Zimbabwe
by: Maritha Kasambala, et al.
Published: (2023-04-01)

Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium
by: F Mutapi, et al.
Published: (2007-06-01)

Algorithm for diagnosis of early Schistosoma haematobium using prodromal signs and symptoms in pre-school age children in an endemic district in Zimbabwe.
by: Tariro L Mduluza-Jokonya, et al.
Published: (2021-08-01)

In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination.
by: Javier Sotillo, et al.
Published: (2019-05-01)

Diagnostic performances of Schistosoma haematobium and Schistosoma mansoni recombinant proteins, peptides and chimeric proteins antibody based tests. Systematic scoping review.
by: Arthur Vengesai, et al.
Published: (2023-01-01)

Diagnostic performances of Schistosoma haematobium and Schistosoma mansoni recombinant proteins, peptides and chimeric proteins antibody based tests. Systematic scoping review
by: Arthur Vengesai, et al.
Published: (2023-01-01)

Effect of treating <it>Schistosoma haematobium </it>infection on <it>Plasmodium falciparum-specific </it>antibody responses
by: Mduluza T, et al.
Published: (2008-11-01)

Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers.
by: Gebeyaw G Mekonnen, et al.
Published: (2022-01-01)

Plasma metabolite profiling for S. haematobium biomarkers of infection in pre-school aged children in Shamva District, Zimbabwe
by: Herald Midzi, et al.
Published: (2024-03-01)

Identifying and evaluating field indicators of urogenital schistosomiasis-related morbidity in preschool-aged children.
by: Welcome M Wami, et al.
Published: (2015-03-01)

T cell clones from Schistosoma haematobium infected and exposed individuals lacking distinct cytokine profiles for Th1/Th2 polarisation
by: Mduluza T, et al.
Published: (2001-01-01)

Explaining observed infection and antibody age-profiles in populations with urogenital schistosomiasis.
by: Kate M Mitchell, et al.
Published: (2011-10-01)

Schistosoma haematobium
by: Cristina Corsini Campioli, et al.
Published: (2023-01-01)

Putting the treatment of paediatric schistosomiasis into context
by: Takafira Mduluza, et al.
Published: (2017-04-01)

Group 2 innate lymphoid cell proportions are diminished in young helminth infected children and restored by curative anti-helminthic treatment.
by: Norman Nausch, et al.
Published: (2015-03-01)

Interleukin-10 and tumour necrosis factor alpha promoter region polymorphisms and susceptibility to urogenital schistosomiasis in young Zimbabwean children living in Schistosoma haematobium endemic regions
by: Amos Marume, et al.
Published: (2020-09-01)

Schistosome infection intensity is inversely related to auto-reactive antibody levels.
by: Francisca Mutapi, et al.
Published: (2011-05-01)

Pharmacogenetics of Praziquantel Metabolism: Evaluating the Cytochrome P450 Genes of Zimbabwean Patients During a Schistosomiasis Treatment
by: Grace Zdesenko, et al.
Published: (2022-06-01)

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
by: Kura, K, et al.
Published: (2020)

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
by: Klodeta Kura, et al.
Published: (2020-11-01)

The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection
by: T Mduluza, et al.
Published: (2001-09-01)

Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa
by: David Gurarie, et al.
Published: (2015-10-01)

Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium
by: Nada Abdel Aziz, et al.
Published: (2019-12-01)

Fungal allergic sensitisation in young rural Zimbabwean children: Gut mycobiome and seroreactivity characteristics
by: Lorraine Tsitsi Pfavayi, et al.
Published: (2021-12-01)

Cytokine responses to the anti-schistosome vaccine candidate antigen glutathione-S-transferase vary with host age and are boosted by praziquantel treatment.
by: Claire D Bourke, et al.
Published: (2014-05-01)

CD16 expression on monocytes in healthy individuals but not schistosome-infected patients is positively associated with levels of parasite-specific IgG and IgG1.
by: Laura J Appleby, et al.
Published: (2014-08-01)

Experimental Schistosoma haematobium pulmonary hypertension
by: Biruk Kassa, et al.
Published: (2024-01-01)

CRISPR-assisted test for Schistosoma haematobium
by: Dounia Cherkaoui, et al.
Published: (2023-03-01)

Colon polyps in Schistosoma haematobium schistosomiasis
by: Celso Alberto Chassot, et al.
Published: (1998-01-01)

Schistosoma haematobium Infection and Buruli Ulcer
by: Janet T. Scott, et al.
Published: (2004-03-01)

Population genetic structure of Schistosoma haematobium and Schistosoma haematobium × Schistosoma bovis hybrids among school-aged children in Côte d’Ivoire
by: Angora Etienne K., et al.
Published: (2022-01-01)

The small RNA complement of adult Schistosoma haematobium.
by: Andreas J Stroehlein, et al.
Published: (2018-05-01)

Multiplex peptide microarray profiling of antibody reactivity against neglected tropical diseases derived B-cell epitopes for serodiagnosis in Zimbabwe.
by: Arthur Vengesai, et al.
Published: (2022-01-01)